Standout Papers

Dabigatran versus Warfarin in Patients with Atrial Fibrillation... 2001 2026 2009 2017 7.8k
  1. Dabigatran versus Warfarin in Patients with Atrial Fibrillation (2009)
    Stuart J. Connolly, Michael D. Ezekowitz et al. New England Journal of Medicine
  2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials (2013)
    Christian T. Ruff, Robert P. Giugliano et al. The Lancet
  3. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study (2001)
    Shamir R. Mehta, Salim Yusuf et al. The Lancet
  4. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial (2011)
    Sanjit S. Jolly, Salim Yusuf et al. The Lancet
  5. Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial (2014)
    Benjamin M. Scirica, Eugene Braunwald et al. Circulation
  6. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease (2017)
    Marc P. Bonaca, Patrice Nault et al. Circulation
  7. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study (2010)
    Christopher P. Cannon, Robert A. Harrington et al. The Lancet
  8. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. (1981)
    N.E. Miller, S Saltissi et al. BMJ
  9. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial (2017)
    Marc S. Sabatine, Lawrence A. Leiter et al. The Lancet Diabetes & Endocrinology

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 215 standout
Sub-graph 1 of 16

Citing Papers

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Stroke
2024 Standout

Works of Basil S. Lewis being referenced

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout

Author Peers

Author Last Decade Papers Cites
Basil S. Lewis 18835 6079 2214 6722 274 24.4k
Gilles Montalescot 22451 12008 3190 5700 546 27.9k
Renato D. Lópes 14286 4467 1293 3940 594 20.5k
Stefan James 20923 11130 3982 3971 483 25.8k
James E. Dalen 11661 5183 2008 6460 203 18.1k
Manesh R. Patel 21648 9010 8591 6367 526 29.7k
Debabrata Mukherjee 20481 11394 6419 3040 447 28.9k
Peter B. Berger 15768 10270 3535 3435 350 22.0k
Jonathan L. Halperin 28140 3136 2642 9327 296 33.9k
Robert P. Giugliano 17451 13091 3367 4456 544 29.3k
Shinya Goto 10423 4116 949 3705 288 14.7k

All Works

Loading papers...

Rankless by CCL
2026